Use of docking peptides to design modular substrates with high efficiency for mitogen-activated protein kinase

Related Experiment Video

Updated: Jul 11, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Neychelle Fernandes1, Denise E Bailey, David L Vanvranken

  • 1Department of Chemical Engineering and Materials Science, University of California, Irvine, California 92697, USA.

ACS Chemical Biology
|October 9, 2007
PubMed

Insights

Researchers developed modular peptide substrates to improve understanding of extracellular regulated kinase (ERK) activity. These substrates enhance ERK phosphorylation efficiency and specificity, aiding cancer research and therapeutic development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The mitogen-activated protein kinase extracellular regulated kinase (ERK) is crucial for cellular proliferation, with mutations found in 30% of malignant tumors.
  • Understanding ERK substrate identification and activity monitoring is vital for cancer research and developing targeted therapies.
  • ERK utilizes a binding site distinct from its catalytic site to interact with upstream activators and downstream substrates.

Purpose of the Study:

  • To investigate the impact of appending docking peptides to phosphorylation sequences on ERK substrate efficiency and specificity.
  • To develop simple, modular peptide substrates for enhanced ERK activity assays and research.

Main Methods:

  • Appending short docking peptides, derived from known ERK substrates and activators, to canonical phosphorylation sequences.
  • Characterizing the kinetic parameters (affinity, maximal velocity) of these modified peptide substrates with ERK.
  • Assessing the specificity of the modified substrates for ERK.

Main Results:

  • Appending docking peptides increased ERK affinity for phosphorylation sequences by up to 200-fold.
  • The efficiency of the phosphorylation reaction was enhanced by up to 150-fold.
  • Maximal reaction velocity was only slightly diminished, and substrate specificity for ERK was maintained.

Conclusions:

  • Simple modular peptide substrates can be tailored for high phosphorylation efficiencies, significantly improving ERK substrate interactions.
  • These enhanced substrates provide a valuable tool for advancing the understanding of ERK regulation.
  • The developed peptide substrates offer a promising avenue for the creation of novel kinase assays for cancer research.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: